...摘要： 目的:探讨血清甲状腺球蛋白(Tg)和131I-全身显像(131I-WBS)联合检查在分化型甲状腺癌(differentiated thyroid carcinoma,DTC)患者手术+ 131I治疗后随访中的临床价值.
基于2个网页-相关网页
目的诊断剂量131i在分化型甲状腺癌放疗中是否存在顿抑现象。
Objective To investigate whether or not the stunning phenomenon presents with diagnostic dose of 131i in differentiated thyroid cancer radiotherapy.
结论 在分化型甲状腺癌患者的131I清甲治疗中，残余甲状腺大小和131I治疗剂量是影响清甲效果的主要因素。
Conclusion The volume of thyroid residue and ablative dose are the main factors for the efficacy of 131I thyroid ablation for DTC.
相似的，在449名未曾治疗的分化型 甲状腺癌老年患者中，91%还活着，40名去世的人中只有8人死 于 甲状腺癌症。
Similarly, among 449 of his older patients with previously untreated DTC, 91% are alive, and only 8 of the 40 who died, died of thyroid cancer.
应用推荐